Anne Dormond-Meuwly
University Hospital of Lausanne(CH)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Cancer Mechanisms and Therapy, Polyamine Metabolism and Applications, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo(2010)88 cited
- → Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib(2011)70 cited
- → Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives(2011)52 cited
- → Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells(2012)44 cited
- → PGE2-induced colon cancer growth is mediated by mTORC1(2014)41 cited
- Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.(2010)
- → The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors(2011)26 cited
- → Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects(2013)21 cited
- → Targeting the JNK Signaling Pathway Potentiates the Antiproliferative Efficacy of Rapamycin in LS174T Colon Cancer Cells(2011)12 cited
- → mTOR Inhibition and the Tumor Vasculature(2012)4 cited